Close Menu

NEW YORK (GenomeWeb) – France's Institut Curie will test the efficacy of Freenome's artificial intelligence-powered genomics platform for studying changes in circulating cell-free DNA to predict patient response to immuno-oncology treatments, the partners said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.